| abstract |
Disclosed is a pharmaceutical preparation or a food for treating and/or preventing metabolic syndrome, obesity, hyperglycemia, hyperlipemia and/or fatty liver, which comprises a compound represented by general formula (I), (II) or (III), particularly SMTP-7, -14, -19, -43D or -44D. (In general formula (I), n represents an integer of 0 to 10.) (In general formula (II), R1 may be present or absent, and R1 represents at least one -OH group when R1 is present; and n2 represents an integer of 0 or 1.) (In formula (III), R2 may be present or absent, R2 represents at least one substituent selected from the group consisting of a -OH group and a -COOH group when R2 is present.) |